Skip to main content
Megan Clowse, MD, Rheumatology, Durham, NC

MeganClowseMD

Rheumatology Durham, NC

Associate Professor, Medicine, Duke University School of Medicine

Dr. Clowse is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Clowse's full profile

Already have an account?

  • Office

    Duke Medical Ctr
    Durham, NC 27710
    Phone+1 919-620-4467

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Rheumatology, 2003 - 2005
  • MedStar Health (Baltimore)
    MedStar Health (Baltimore)Residency, Internal Medicine, 1999 - 2002
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1999

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2005 - 2025
  • MD State Medical License
    MD State Medical License 2003 - 2006
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow American College of Rheumatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Patient‐Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis  
    Nathaniel Harris, Megan Clowse, Arthritis Care & Research

Other

Authored Content

  • Dapirolizumab Pegol Demonstrated Significant Improvement in Systemic Lupus Erythematosus Disease Activity: Efficacy and Safety Results of a Phase 3 TrialOctober 2024
  • Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic PainApril 2016
  • Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic PainApril 2016
  • Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic PainReporting of Sex Effects by Systematic Reviews on InterventionsApril 2016
  • Join now to see all

Press Mentions

  • Dapirolizumab Pegol Reduces SLE Activity & Corticosteroid Use
    Dapirolizumab Pegol Reduces SLE Activity & Corticosteroid UseDecember 16th, 2024
  • Belimumab for Pregnant Women with Lupus: B-cell Concerns Remain
    Belimumab for Pregnant Women with Lupus: B-cell Concerns RemainJanuary 17th, 2023
  • Belimumab for Pregnant Women with Lupus: B-cell Concerns Remain
    Belimumab for Pregnant Women with Lupus: B-cell Concerns RemainJanuary 17th, 2023
  • Join now to see all